BCWORLD PHARM. Co., Ltd.

KOSDAQ:A200780 Stock Report

Market Cap: ₩40.8b

BCWORLD PHARM Balance Sheet Health

Financial Health criteria checks 1/6

BCWORLD PHARM has a total shareholder equity of ₩75.1B and total debt of ₩86.2B, which brings its debt-to-equity ratio to 114.8%. Its total assets and total liabilities are ₩171.2B and ₩96.1B respectively. BCWORLD PHARM's EBIT is ₩432.3M making its interest coverage ratio 0.1. It has cash and short-term investments of ₩7.0B.

Key information

114.8%

Debt to equity ratio

₩86.24b

Debt

Interest coverage ratio0.09x
Cash₩7.01b
Equity₩75.10b
Total liabilities₩96.08b
Total assets₩171.18b

Recent financial health updates

Recent updates

Does BCWORLD PHARM (KOSDAQ:200780) Have A Healthy Balance Sheet?

Dec 04
Does BCWORLD PHARM (KOSDAQ:200780) Have A Healthy Balance Sheet?

Investors Shouldn't Be Too Comfortable With BCWORLD PHARM's (KOSDAQ:200780) Earnings

Mar 18
Investors Shouldn't Be Too Comfortable With BCWORLD PHARM's (KOSDAQ:200780) Earnings

BCWORLD PHARM (KOSDAQ:200780) Seems To Be Using A Lot Of Debt

Mar 01
BCWORLD PHARM (KOSDAQ:200780) Seems To Be Using A Lot Of Debt

Does The Market Have A Low Tolerance For BCWORLD PHARM. Co., Ltd.'s (KOSDAQ:200780) Mixed Fundamentals?

Feb 09
Does The Market Have A Low Tolerance For BCWORLD PHARM. Co., Ltd.'s (KOSDAQ:200780) Mixed Fundamentals?

Is BCWORLD PHARM. Co., Ltd. (KOSDAQ:200780) A Good Dividend Stock?

Jan 25
Is BCWORLD PHARM. Co., Ltd. (KOSDAQ:200780) A Good Dividend Stock?

If You Had Bought BCWorld Pharm (KOSDAQ:200780) Stock A Year Ago, You Could Pocket A 75% Gain Today

Jan 11
If You Had Bought BCWorld Pharm (KOSDAQ:200780) Stock A Year Ago, You Could Pocket A 75% Gain Today

Do Insiders Own Lots Of Shares In BCWorld Pharm Co., Ltd. (KOSDAQ:200780)?

Dec 26
Do Insiders Own Lots Of Shares In BCWorld Pharm Co., Ltd. (KOSDAQ:200780)?

Are BCWorld Pharm's (KOSDAQ:200780) Statutory Earnings A Good Guide To Its Underlying Profitability?

Dec 08
Are BCWorld Pharm's (KOSDAQ:200780) Statutory Earnings A Good Guide To Its Underlying Profitability?

Is BCWorld Pharm (KOSDAQ:200780) A Risky Investment?

Nov 18
Is BCWorld Pharm (KOSDAQ:200780) A Risky Investment?

Financial Position Analysis

Short Term Liabilities: A200780's short term assets (₩38.8B) do not cover its short term liabilities (₩80.9B).

Long Term Liabilities: A200780's short term assets (₩38.8B) exceed its long term liabilities (₩15.2B).


Debt to Equity History and Analysis

Debt Level: A200780's net debt to equity ratio (105.5%) is considered high.

Reducing Debt: A200780's debt to equity ratio has increased from 63.6% to 114.8% over the past 5 years.

Debt Coverage: A200780's debt is not well covered by operating cash flow (8.3%).

Interest Coverage: A200780's interest payments on its debt are not well covered by EBIT (0.1x coverage).


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 12:58
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

BCWORLD PHARM. Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution